Chemical Diversity Research Institute (CDRI) - is a contract research organization focused on pre-clinical and clinical R&D from target identification to clinical candidate nomination and Proof of Concept in human. CDRI sees its mission in enabling discovery and development of innovative therapies for unmet needs utilizing highest expertise and innovation potential of Russian scientists with integrated external R&D solutions of Discovery outSource ^TM platforms. Since 1990 we continue extending quality R&D services in CNS, oncology, inflammation, CV and metabolic disease area to our pharma and biotech partners.

Discovery outSource ^TM platform solutions cover the complete range of disciplines from identification of a biological target (protein expression, assay development etc.); to clinical drug candidates (ADME/DMPK, toxicity and safety studies, in vivo animal models, drug formulation etc.); to drug development candidate (Phase I to Phase IV).

CDRI collaboration network encompasses hundreds of scientific institutions and individual research groups in Russia, CIS countries and rest of the world. The Institute has established broad cooperation with the Moscow State University, Moscow Institute of Physics and Technology, D. Mendeleev University of Chemical Technology of Russia and other in science and education fields. CDRI offers internships, graduate and postdoctoral positions to young scientists, attracting returnees with US and European industrial experience thus enhancing the core basic and application sciences and pharmaceutical industrial expertise in Russian Federation.

CONTACT

Phone: +7 (495) 225 11 92

Fax: +7 (495) 626 97 80

E-mail: iihr@iihr.ru